Showing results (2091-2100 of 2,132) with videos related to

Sort By:
Pageof 214
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2016
Drug-resistant tuberculosis clinical trials: proposed core research definitions in adultsJ Furin, E Alirol, E Allen, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivativesMichael E Kort, Robert N Atkinson, James B Thomas, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic painIrene Drizin, Robert J Gregg, Marc J C Scanio, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 25, 2025
International multidisciplinary consensus recommendations on clinical application of three-dimensional visualization in precision surgery for pediatric liver tumorsQian Dong, Wenli Xiu, Benjie Tang, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Biallelic variants in MRPL49 cause variable clinical presentations, including sensorineural hearing loss, leukodystrophy, and ovarian insufficiencyHuw B Thomas, Leigh A M Demain, Alfredo Cabrera-Orefice, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2014
Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortiumMichael B Cook, Pascal Guénel, Susan M Gapstur, et al.
Genome Announcements|June 20, 2015
Genome Sequences of Cluster G Mycobacteriophages Cambiare, FlagStaff, and MOOREtheMARYerWelkin H Pope, David A Augustine, Daniel C Carroll, et al.
The Lancet. Infectious Diseases|September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trialVictoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Pageof 214